CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-07 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise · Restricted Stock Units | −1,489 | 0 | ||
| 2024-04-05 | DAVIS STEPHEN CEO | Option exercise | +17,333 | 136,175 | ||
| 2024-04-05 | DAVIS STEPHEN CEO | Option exercise | +34,666 | 170,841 | ||
| 2024-04-05 | DAVIS STEPHEN CEO | Option exercise · Restricted Stock Units | −17,333 | 34,667 | ||
| 2024-04-05 | DAVIS STEPHEN CEO | Option exercise · Restricted Stock Units | −34,666 | 138,666 | ||
| 2024-04-05 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Option exercise | +5,024 | 41,364 | ||
| 2024-04-05 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Option exercise · Restricted Stock Units | −5,024 | 10,048 | ||
| 2024-04-05 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise | +2,010 | 13,401 | ||
| 2024-04-05 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise · Restricted Stock Units | −2,010 | 4,020 | ||
| 2024-04-05 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise | +5,275 | 31,458 | ||
| 2024-04-05 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −5,275 | 10,551 | ||
| 2024-03-27 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Sale | −5,140 | $17.90 | $92K | 36,340 |
| 2024-03-27 | DAVIS STEPHEN CEO | Sale | −17,714 | $17.90 | $317K | 118,842 |
| 2024-03-27 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Sale | −5,434 | $17.90 | $97K | 26,183 |
| 2024-03-25 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Grant or award · Stock Options (Right to Buy) | +13,964 | 13,964 | ||
| 2024-03-25 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Grant or award · Restricted Stock Units | +8,568 | 8,568 | ||
| 2024-03-25 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Grant or award | +10,048 | 41,480 | ||
| 2024-03-25 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Grant or award · Stock Options (Right to Buy) | +89,516 | 89,516 | ||
| 2024-03-25 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Grant or award · Restricted Stock Units | +27,460 | 27,460 | ||
| 2024-03-25 | DAVIS STEPHEN CEO | Grant or award | +34,666 | 136,556 |
Page 14 of 63 · 1,260 trades